NCT07445711

Brief Summary

Uterine involution, the process by which the uterus returns to its pre-pregnancy size during the postpartum period, can cause severe cramp-like pain in postpartum women. Although pharmacological methods are common for managing this pain in the literature, their side effects limit their use in this population. This project aims to fill a significant gap in the literature by combining guided imagery, a non-pharmacological technique, with evolving artificial intelligence (AI) technologies. While the effectiveness of guided imagery in cesarean and labor pain is well-known, its impact on pain and physiological parameters during uterine involution-specifically through AI-supported visualization-will be evaluated for the first time within the scope of this study. The primary research question of the project is: "Do guided imagery and AI-supported video applications have a healing effect on the pain levels and vital signs of postpartum women during the evaluation of uterine involution?" This research is a three-arm, randomized controlled experimental study to be conducted at Istanbul Atlas University Hospital. The sample size of the study was determined using the G\*Power 3.1 program. As a result of the a priori power analysis performed by selecting the "ANOVA: Fixed effects, omnibus, one-way" statistical test under the "F tests" family, the significance level was set at α = 0.05, the statistical power (1-β) at 0.80, and the effect size (f) at 0.25 (medium effect). The analysis indicated a total sample size of 159 participants for the three groups, with 53 participants required in each group. To account for potential sample attrition, a 10% addition was made to each group, resulting in a planned study with 59 participants per group and a total of 177 participants. "Guided Imagery" and "AI-Supported Video" applications will be utilized as intervention methods. In the guided imagery group, an expert-approved original audio script titled "The Emotional Journey of Mother and Baby" will be played to the women via over-ear headphones during the uterine involution assessment. In the AI-supported video group, a video generated with AI prompts based on the same script will be shown using virtual reality (VR) goggles during the assessment. This will allow for a comparative analysis of the effects of visual and auditory stimuli on pain during the uterine involution evaluation. Participants' pain levels will be measured using the VAS scale, and physiological data (pulse, blood pressure, SpO₂) will be recorded by monitoring at the 60th, 120th, and 180th seconds of the involution process. Considering the moderating effect of anxiety on pain threshold and vital signs, the 'Postpartum Specific Anxiety Scale' will be administered to all participants before the intervention. Data will be analyzed using ANOVA and Kruskal-Wallis tests in the SPSS 23 program.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
150

participants targeted

Target at P75+ for not_applicable

Timeline
6mo left

Started Feb 2026

Shorter than P25 for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress35%
Feb 2026Dec 2026

First Submitted

Initial submission to the registry

February 25, 2026

Completed
3 days until next milestone

Study Start

First participant enrolled

February 28, 2026

Completed
3 days until next milestone

First Posted

Study publicly available on registry

March 3, 2026

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Last Updated

March 3, 2026

Status Verified

February 1, 2026

Enrollment Period

10 months

First QC Date

February 25, 2026

Last Update Submit

February 25, 2026

Conditions

Keywords

Artificial IntelligenceGuided ImageryPainPostpartum WomenUterine Involution

Outcome Measures

Primary Outcomes (1)

  • Uterus involution pain

    Pain intensity as measured by the Visual Analog Scale (VAS).

    first one hour after birth

Study Arms (3)

Guided Imagery Group

EXPERIMENTAL

Guided Imagery Group

Behavioral: Guided Imagery Group

AI-Powered Video Group

EXPERIMENTAL

AI-Powered Video Group

Behavioral: AI-Powered Video Group

Control group

OTHER

Control group

Behavioral: Control Group

Interventions

Definition: This group will receive a guided imagery intervention designed to focus the mind on relaxing images and reduce the perception of pain. Procedure: Before the uterine involution assessment begins, participants will listen to a structured audio recording (via headphones) that guides them through relaxation techniques and mental imagery. Implementation: The intervention will continue throughout the assessment process to manage pain and anxiety.

Guided Imagery Group

Definition: This group will be exposed to a visual and auditory intervention created using artificial intelligence (AI) tools. Procedure: Participants will watch a high-fidelity, AI-generated video (e.g., via a tablet or VR goggles) specifically designed to provide cognitive distraction and physiological calming. Implementation: The video, which synchronizes calming visuals with rhythmic audio, will be played during the uterine involution evaluation to evaluate its impact on pain and vital signs.

AI-Powered Video Group
Control GroupBEHAVIORAL

Definition: Participants in this group will receive standard postpartum care and routine clinical monitoring. Procedure: Uterine involution assessment will be performed according to the standard hospital protocol without any additional psychological or technological intervention. Data Collection: Physiological parameters and pain levels will be recorded during and after the routine assessment.

Control group

Eligibility Criteria

Age18 Years+
Sexfemale(Gender-based eligibility)
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age: Postpartum women aged 18 years and older.
  • Obstetric History: Primiparous women who have had a vaginal delivery.
  • Procedure: Presence of an episiotomy during vaginal delivery.
  • Physical Condition: Absence of physical conditions (e.g., postpartum hemorrhage, risk of sepsis) that would interfere with the safe assessment of uterine involution or the implementation of interventions.
  • Technological Competence: Ability to participate in guided imagery and AI-powered video interventions, including the seamless use of digital equipment such as headphones and goggles.
  • Consent: Voluntarily agreeing to participate and signing the informed consent form.

You may not qualify if:

  • Medication: Use of analgesic or opioid medications within the last 4-6 hours.
  • Mental Health: History of or current mental health disorders, such as anxiety or depression.
  • Medical Urgency: Requiring intensive care treatment or experiencing medical emergencies during hospitalization.
  • Neonatal Status: Having a newborn admitted to the Neonatal Intensive Care Unit (NICU).
  • Chronic Illness: Diagnosis of any chronic disease.
  • Study Continuity: Inability to continue the study for any reason (e.g., withdrawal due to medical emergencies).
  • Psychological History: Having received or currently receiving psychotherapy or psychological interventions.
  • Communication Barriers: Language barriers or communication difficulties that prevent the accurate application of research tools.
  • Sensory Impairments: Presence of visual or auditory impairments.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Pain

Interventions

Control Groups

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Epidemiologic Research DesignEpidemiologic MethodsInvestigative TechniquesResearch DesignMethods

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PhD Student

Study Record Dates

First Submitted

February 25, 2026

First Posted

March 3, 2026

Study Start

February 28, 2026

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

December 31, 2026

Last Updated

March 3, 2026

Record last verified: 2026-02

Data Sharing

IPD Sharing
Will not share